North America Poultry Vaccines Market: By Vaccine Type, By Formulation Vaccines, Liquid Vaccines, Freeze Dried Vaccines), By Application and Country
North America Poultry Vaccines Market size was valued at US$ 908.6 million in 2023 and is poised to grow at a CAGR of 6.2% from 2024-2030. Vaccines are biological preparations that provide acquired immunity to particular diseases in human beings or animals. Poultry vaccines are used to prevent or cure various diseases in poultry such as Marek's disease, Newcastle disease, and infectious diseases among others. However, stringent regulatory guidelines for vaccine approvals, adverse effects associated with vaccines, and high costs for R&D activities may restrain the growth of the poultry vaccines market in future years. Any type of domesticated bird bred in captivity for its usefulness is referred to as poultry. Historically, the term has only been used to apply to waterfowl (Anseriformes) and wildfowl (Galliformes), not cagebirds like parrots and songbirds. The term "poultry" refers to domestic birds, such as chickens, turkeys, geese, and ducks, that are raised for their meat or eggs. It also refers to the bird flesh that is consumed.
Increase in the demand for healthy meat and poultry products, rise in R&D activities for the innovation of newer poultry vaccines, escalation in prevalence of various diseases such as avian flu in poultry, and high awareness about the poultry diseases among veterinary professionals are expected to boost the North America poultry vaccines market over the forecast period.
North America poultry vaccines market is segmented into U.S. and Canada. U.S. poultry vaccines market is growing due to rise in population demanding for healthy meat, increase in R&D activities for the innovation of newer vaccines, and rise in prevalence of infectious diseases are bolster the market. Canada poultry vaccines market expected to exhibit significant growth rate owing to increase in the poultry production (according to Agriculture and Agri-Food Canada, Canada produced approximately USD 4.3 Bn poultry and egg products in 2016) and adoption of newer vaccines are fuel the market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Market Size in 2023 |
US$ 908.6 million |
|
By Vaccine Type |
|
|
By Formulation |
|
|
By Application |
|
Download Free Sample Report
2023 is the base year and 2030 is the forecast year.
The north america poultry vaccines market report covers the market data: United States, Canada
The north america poultry vaccines market key players are Arko Laboratories, Merck & Co. Inc., Boehringer Ingelheim Vetmedica, Elanco, Bayer Animal Health, Ceva Sante Animale, Zydus AHL, Phibro Animal Health Corporation
| 1.Executive Summary |
| 2. North America Poultry Vaccines Market Introduction |
| 2.1. North America Poultry Vaccines Market - Taxonomy |
| 2.2. North America Poultry Vaccines Market - Definitions |
| 2.2.1.Vaccine Type |
| 2.2.2.Formulation |
| 2.2.3.Application |
| 2.2.4.Country |
| 3. North America Poultry Vaccines Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. North America Poultry Vaccines Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. North America Poultry Vaccines Market By Vaccine Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Inactivated Vaccines |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Live Attenuated Vaccines |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Recombinant Vaccines |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. North America Poultry Vaccines Market By Formulation, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Dry Form (Duct) Vaccines |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Liquid Vaccines |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Freeze Dried Vaccines |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. North America Poultry Vaccines Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Marek's Disease |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Newcastle Disease |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Infectious Bursal Disease |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Infectious Bronchitis |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Poultry Vaccines Market By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. United States of America (USA) |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Canada |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9.United States of America (USA) Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Inactivated Vaccines |
| 9.1.2.Live Attenuated Vaccines |
| 9.1.3.Recombinant Vaccines |
| 9.2. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Dry Form (Duct) Vaccines |
| 9.2.2.Liquid Vaccines |
| 9.2.3.Freeze Dried Vaccines |
| 9.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Marek's Disease |
| 9.3.2.Newcastle Disease |
| 9.3.3.Infectious Bursal Disease |
| 9.3.4.Infectious Bronchitis |
| 9.3.5.Others |
| 10.Canada Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Inactivated Vaccines |
| 10.1.2.Live Attenuated Vaccines |
| 10.1.3.Recombinant Vaccines |
| 10.2. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Dry Form (Duct) Vaccines |
| 10.2.2.Liquid Vaccines |
| 10.2.3.Freeze Dried Vaccines |
| 11. Competition Landscape |
| 11.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 11.2.1.Bayer Animal Health |
| 11.2.2.Ceva Sante Animale |
| 11.2.3.Boehringer Ingelheim Vetmedica |
| 11.2.4.Elanco |
| 11.2.5.Zoetis |
| 11.2.6.Zydus AHL |
| 12. Research Methodology |
| 13. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.
Download Free Sample
